In this study, rheumatoid hands were divided into groups by cluster analysis using parameters related to representative deformities, and alterations in deformity and function over time were compared with covariates of disease duration. Although there have been reports on the incidence of hand deformities in rheumatoid arthritis within 10 years from its onset and comparisons of grip strength by existing hand deformity[2, 3], comprehensive assessment of rheumatoid hand, including thumb deformity, and their alterations over time are not reported, to the best of our knowledge.
Clusters 1–4 of the five clusters had similar disease duration but wide variation in deformities, meaning that the period of time hand joints became symptomatic from the onset of RA was the same in clusters 1–4, but cumulative damage to the joints differed between the clusters. Cumulative disease activity in RA has been shown to affect the prognosis of the joint[13]; therefore, differences in the degree of deformity between clusters indicate a difference in outcomes with long-term drug therapy from the onset. Generally, it is impossible to know the exact relationship between differences between clusters and disease activity because it is not possible to know the progressive disease activity of patients since their disease onset. However, in any case, a large difference in hand phenotypes emerged in the approximately 17-years of patients’ disease duration. The hand clusters in this study revealed a typical pattern of deformity progression, and we identified a subset in which only mild and few deformities developed, which is good news, clinically. Conversely, type 2 and 3 thumb deformities are a factor to consider treating aggressively, as these types are often considered to be a subset of strong functional impairment complicated by severe ulnar drift.
The remaining cluster (cluster 5) had the least functioning hands, with severe thumb deformity combined with severe swan-neck deformity and with a longer disease duration than the other clusters. In this study, we did not reclassify hands in 2009 and 2015 classified by the parameters in 2004, using methods such as discriminant analysis for moves between clusters that could be followed in 2009 or 2015. Therefore, it is unclear whether hands moved between clusters over time. However, significant swan-neck deformity scores in the hands in cluster 5 indicate that swan-neck deformity exists in all fingers. Therefore, we believe it is reasonable to assume that cluster 5 developed swan-neck deformity early in disease duration versus the possibility of progression to swan-neck deformity from other clusters. Hands with swan-neck deformities had the least function in previous reports,[1, 2, 14], and our results were similar. In addition, approximately half of the patients this group also have type 6 thumb deformity (mutilans deformity) [15], which also significantly affects hand function. Therefore, because the treatment of type 6 thumb deformity and severe swan-neck deformity is still "challenging work", it seems reasonable to treat while the joint destruction is milder. Further research to investigate the limitations of surgical treatment are warranted.
Regarding alterations in deformity over time, swan-neck deformity progressed over time, whereas boutonnière deformity and ulnar drift did not progress significantly. However, the results of the longitudinal plots show a decrease in boutonnière deformity scores and an increase in ulnar drift scores for some clusters. Regarding the boutonnière deformity score, cases with severe deformity dropping out of the study, rather than showing improvement in deformity, caused the score improvement, which does not mean that deformity improves over time. In contrast, regarding the ulnar drift score, groups were clearly divided into progressive and non-progressive deformities. Ulnar drift has been reported to increase over time[3], and function is also reported to worsen with time[16]. In our study, only 63 hands were available in 2015, suggesting the possibility of a type II error. In addition, regarding function, there was no significant difference between the assessment scores over time; in fact, some groups showed a slight increase in mean scores. Overall, however, the deformity parameters deteriorated, suggesting that factors other than deformity may have influenced the results. During the 11-year observation period, C-reactive protein concentration and erythrocyte sedimentation rates) improved. The number of biologics used in this study increased from 3 (4.5%) in 2004, to 7 (13.5%) in 2009, and to 13 (35.1%) in 2015. The effect of biologics on improving hand function has been widely reported[17], and their increased use might also have improved the scores in the present study.
Regarding thumb deformities, the Nalebuff classification divided thumbs into six types by the initially affected joint and its appearance[15, 18], and type change over time was not considered. Additionally, to our knowledge, no studies have compared hand function by type, and none have quantified the impact of deformity type on hand function. Our results showed that type 1 is the primary phenotype in thumb deformity, and type 2 and 4 are secondary lesions of type 1. Seven of our type 2 cases changed from type 1, which may be explained by initial flexion contracture of the metacarpophalangeal joint with secondary carpometacarpal joint involvement. In contrast, change to type 3, which initially involves the carpometacarpal joint, occurred mainly in thumbs without deformity, except for one case. Therefore, type 3 is also a primary phenotype, as is type 1. We observed no patients in whom thumb deformity altered to type 6, in this study, but it is well known that type 6 is the final form of joint destruction, known as “mutilans”. The underlying mechanisms influencing these phenotype differences are still unknown, but our results may raise controversy regarding the underlying pathological mechanism of thumb deformities.
Quantifying finger deformities, specifically swan-neck deformity and boutonnière deformity, was challenging in this study. Anatomically, the index to little fingers have different roles. The index and middle fingers are mainly used in extension for reach behaviors, in contrast to the ring and little fingers, which work in flexion while grasping. Therefore, the affected finger should be considered when interpreting our results. A previous study evaluated each affected finger separately[19], but the authors did not evaluate the proximal interphalangeal joint and did not describe the finger deformity phenotypes. Another study reported the results of a stratified analysis by finger among patients who underwent surgery with silicone arthroplasty. The authors reported that the ring and little fingers had larger extension lags[20], but the authors did not describe hand function. A study evaluating finger deformity separately showed an almost even distribution for the characteristic finger deformities from the index to little fingers[4]. However, to our knowledge, no patient-rated subjective indicator evaluating hand function assesses fingers separately; therefore, the absence of weighting impact on function difference by each finger would have minimal impact on the results.
In this study, the swan-neck deformity scores and boutonnière deformity scores were treated equally and entered into the cluster analysis. Several studies have shown that swan-neck deformity indicates more severe disability than boutonnière deformity[1, 2, 14]. This suggests that scores from swan-neck deformity should be weighted; however, our previous study showed that both deformities contribute equally to hand function. Therefore, we used the same quantification method, in this study.
Our results suggest several paths of hand deformity progression after the onset of RA (Fig. 4). Because this study was not a follow-up study from the onset, we cannot indicate the proportions of the conservative and progressive subsets (Fig. 4). However, in the clusters in this study, many of the hands fit into the conservative subset, indicating milder deformities, which is fortunate for the patients, clinically. Of course, it should not be forgotten that type 1 thumb deformity also involves strong functional deficits as it progresses [10], and, therefore, requires early treatment. Minimal swan-neck or boutonnière deformity is considered to constitute the conservative subset, whereas multiple deformities constitute the progressive subset. Initially, it is difficult to determine the subset, but more attention should be paid to swan-neck deformity as this deformity progressed in our 11-year observation after the paradigm shift in drug therapy. Type 2 and 3 thumb deformities may also be an indicator of the progressive subset, complicated by severe ulnar drift. Similarly, type 6 thumb deformity is a clear indicator of progression and is a target for treatment because this deformity causes severe clinical functional impairment.
This study has several limitations. First, because our cohort was not followed from the onset of RA, we are unable to show how deformities developed in each subset. If we were able to show the proportion of occurrence and which deformities occurred first, we might have been able to provide a better indication of treatment. Second, the cluster analysis assigned hands to each cluster group retrospectively. Therefore, our clusters are explanatory research and cannot necessarily be applied to new single hands; additional studies are needed. Third, the results of this study could have been more meaningful if it was clear which type of thumb deformity was more disabling. A further comparison of thumb deformity in another cohort is warranted. Fourth, we used the Kapandji index as a functional evaluation. This index is usually used as a functional mobility measure and reflects functional impairment. Therefore, using an index that reflects unilateral disability, such as the Michigan Hand Outcomes Questionnaire[21], the results of this study could be more reflective of disability in the rheumatoid hand. Unfortunately, we were unable to adopt these patient-reported outcome measures at the beginning of the study.